Bio-Techne’s Simple Western Used in FDA Approval of ZEVASKYN™ Therapy
Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in supporting the FDA approval of ZEVASKYN™ (prademagene zamikeracel), the first...